No abstract available
Publication types
-
Letter
-
Randomized Controlled Trial
MeSH terms
-
Angiogenesis Inhibitors / adverse effects
-
Angiogenesis Inhibitors / therapeutic use*
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Bevacizumab
-
Drug Therapy, Combination
-
Glucocorticoids / adverse effects
-
Glucocorticoids / therapeutic use*
-
Humans
-
Intravitreal Injections
-
Optic Neuropathy, Ischemic / drug therapy*
-
Optic Neuropathy, Ischemic / physiopathology
-
Treatment Outcome
-
Triamcinolone Acetonide / adverse effects
-
Triamcinolone Acetonide / therapeutic use*
-
Visual Acuity / physiology
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal, Humanized
-
Glucocorticoids
-
Bevacizumab
-
Triamcinolone Acetonide